Rhodococcus equi is a dangerous pathogen that causes pneumonia in foals that are generally between the ages of 3 weeks and 5 months. In cases caught early on, the foal can make a full recovery with proper treatment. However, in more serious cases the mortality rate is quite high. The disease was discussed in depth during the 2010 American Association of Equine Practitioners convention.
It isn’t for lack of effort that the equine industry still doesn’t have new options for treating Rhodococcus equi pneumonia in foals.
It isn’t for lack of effort that the equine industry still doesn’t have new options for treating Rhodococcus equi pneumonia in foals. “To date, alternatives to macrolides for effective treatment of R. equi pneumonia in foals have not been identified
Although about 30% of foals that develop Rhodococcus equi foal pneumonia do not survive, the majority of foals can be treated successfully and proceed with a normal life. But why is it that only foals are affected by this respiratory disease?
One of the major foal diseases in the United States is Rhodococcus equi foal pneumonia. Responsible for the deaths of up to 30% of infected foals, it is a serious problem at many large breeding farms.
Update on Rhodococcus equi pneumonia in foals by Drs. Noah Cohen of Texas A&M University, Steeve Giguere of the University of Georgia, and M. Julia B. Felippe of Cornell University. (Presented at the 2010 AAEP convention)
For years foal owners have struggled with controlling the bacterium Rhodococcus equi and the infections it causes—some farms manage cases annually, despite following strict farm management strategies to reduce risk of infection.
Current evidence suggests that the most successful treatments are a combination of the drug rifampin and a macrolide (an antimicrobial drug).
R. equi is a dangerous pathogen that causes pneumonia in foals that are generally between the ages of 3 weeks and 5 months. In cases that caretakers and veterinarians catch early on, the foal can make a full recovery with proper treatment. However in more serious cases, the mortality rate is quite high.
What was the hottest news in equine veterinary medicine in 2009? During the popular Kester News Hour session at the annual American Association of Equine Practitioners (AAEP) Convention, three top veterinarians (who focus on equine reproduction
The U.S. Food and Drug Administration has approved Excede sterile suspension, a new long-acting antibiotic formulation for horses from Pfizer Animal Health, the company announced in a release.
Excede Sterile Suspension is used to tre
David Horohov, PhD, the William Robert Mills Chair in Equine Immunology at the University of Kentucky’s Maxwell H. Gluck Equine Research Center, has received a $200,000 grant from the USDA-CSREES Competitive Grants Program to study the development of immunological responses in foals.
Rhodococcus equi bronchopneumonia is a prevalent cause of disease in foals, said M. Keith Chaffin, DVM, MS, Dipl. ACVIM, a professor of medicine at Texas A&M University’s vet school, at the 2008 American Association of Equine Practitioners convention, which was held Dec. 6-10 in San Diego, Calif.
A problem in eastern Canada, the United States, and internationally, R. equi is a soil bacterium that causes severe pneumonia in foals.
A product that could stimulate the immune systems of newborn foals to better fight infection of Rhodococcus equi would be very beneficial, said Steeve Giguère, DVM, PhD, of the University of Florida, at the 2008 American Association of Equine
If you work around horses long enough, you’ll be handling ones that have lameness, diarrhea, abortions, skin diseases, and even neurologic signs. Our first concern is generally for the
Stay on top of the most recent Horse Health news with
